- Home
- WST vs CBOE Comparison
WST vs CBOE Comparison
Compare WST & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- CBOE
- Stock Information
- Founded
- WST 1923
- CBOE 1973
- Country
- WST United States
- CBOE United States
- Employees
- WST N/A
- CBOE N/A
- Industry
- WST Medical/Dental Instruments
- CBOE Investment Bankers/Brokers/Service
- Sector
- WST Health Care
- CBOE Finance
- Exchange
- WST Nasdaq
- CBOE Nasdaq
- Market Cap
- WST 18.0B
- CBOE 25.6B
- IPO Year
- WST N/A
- CBOE 2010
- Fundamental
- Price
- WST $279.56
- CBOE $233.53
- Analyst Decision
- WST Strong Buy
- CBOE Hold
- Analyst Count
- WST 8
- CBOE 13
- Target Price
- WST $333.71
- CBOE $234.15
- AVG Volume (30 Days)
- WST 618.5K
- CBOE 782.1K
- Earning Date
- WST 10-23-2025
- CBOE 10-31-2025
- Dividend Yield
- WST 0.33%
- CBOE 1.20%
- EPS Growth
- WST N/A
- CBOE 18.01
- EPS
- WST 6.68
- CBOE 8.52
- Revenue
- WST $2,960,200,000.00
- CBOE $4,531,800,000.00
- Revenue This Year
- WST $6.28
- CBOE N/A
- Revenue Next Year
- WST $6.11
- CBOE $4.38
- P/E Ratio
- WST $40.48
- CBOE $28.12
- Revenue Growth
- WST 2.90
- CBOE 18.98
- 52 Week Low
- WST $187.43
- CBOE $187.30
- 52 Week High
- WST $352.33
- CBOE $255.27
- Technical
- Relative Strength Index (RSI)
- WST 68.14
- CBOE 42.80
- Support Level
- WST $260.12
- CBOE $233.53
- Resistance Level
- WST $265.66
- CBOE $246.64
- Average True Range (ATR)
- WST 5.66
- CBOE 5.08
- MACD
- WST 0.56
- CBOE -0.63
- Stochastic Oscillator
- WST 86.56
- CBOE 8.50
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.